Antitumor efficacy of N1, N11-diethylnorspermine on a human bladder tumor xenograft in nude athymic mice

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1239-1244

  Sharma, Amarnath ^a,c   Glaves, Dorothy ^b   Porter, Carl W ^a   Raghavan, Derek ^b   Bernacki, Ralph J ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N,N DIETHYLNORSPERMINE; SPERMINE DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; N(1),N(11) DIETHYLNORSPERMINE; N(1),N(11)-DIETHYLNORSPERMINE; PUTRESCINE; SPERMIDINE; SPERMINE;

ADOLESCENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER TUMOR; CONTROLLED STUDY; CYTOSTASIS; DRUG EFFICACY; FEMALE; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR XENOGRAFT; ANIMAL; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; DRUG EFFECT; HUMAN; METABOLISM; TRANSITIONAL CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; CELL SURVIVAL; HUMANS; MICE; MICE, NUDE; PUTRESCINE; SPERMIDINE; SPERMINE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0030608634     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. American Cancer Society. Cancer Facts & Figures, 1996. Atlanta: American Cancer Society Inc., 1996.
2. Kiemeney, L. A., Witjes, J. A., Heijbroek, R. P., Verbeek, A. L., and Debruyne, F. M. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J. Urol., 150: 60-64, 1993.
3. Raghavan, D., Shipley, W., Garnick, M. B., Russell, P. J., and Richie, J. P. Biology and management of bladder cancer. N. Engl. J. Med., 322: 1129-1138, 1990.
4. 1-acetyltransferase by intracellular polyamine pools: evidence for a functional role in polyamine homeostasis. FEBS Lett., 321: 179-183, 1993.
5. 1-acetyltransferase activity and growth inhibition in human melanoma cell lines. Cancer Res., 51: 3715-3720, 1991.
6. 12-bis(ethyl)spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes. Anticancer Res., 12: 1083-1090, 1992.
7. 11-diethylnorspermine a polyamine analog in advanced cancer. Proc. Am. Soc. Clin. Oncol. Annu. Meet., 14: 472, 1995.
8. Chang, B. K., Liang, Y., Miller, D. W., Bergeron, R. J., Porter, C. W., and Wang, G. Effects of diethyl spermine analogs in human bladder cancer cell lines in culture. J. Urol., 150: 1293-1297, 1993.
9. 12-bis(ethyl)spermine homologs against human MALME-3 melanoma xenografts. Cancer Res., 52: 2424-2430, 1992.
10. 11-bis(ethyl)-norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res., 53: 581-586, 1993.
11. 11 diethylnorspermine administered by multiple injection or continuous infusion. Clin. Cancer Res., 1: 847-857, 1995.
12. Dolan, M. E., Fleig, M. J., Feuerstein, B. G., Basu, H. S., Luk, G. D., Casero, R. A., Jr., and Marton, L. J. Effect of 1,19-bis(ethyl-amino)-5,10,15-triazanonadecane on human tumor xenografts. Cancer Res., 54: 4698-4702, 1994.
13. Russell, P. J., Wass, J., Lukeis, R., Garson, M, O., Jelbart, M., Wills, E., Philips, J., Brown, J., Carrington, N., Vincent, P. C., and Raghavan, D. Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL13. Int. J. Cancer, 44: 276-285, 1989.
14. Russell, P. J., Jelbart, M., Wills, E., Singh, S., Wotherspoon, J., and Raghavan, D. Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation. Int. J. Cancer, 41: 74-82, 1988.
15. Russell, P. J., Palavidis, Z., Rozinova, E., Philips, J., Wills, E. J., Lukeis, R., Wass, J., and Raghavan, D. Establishment and characterization of a new bladder cancer cell line, UCRU-BL28. J. Urol., 150: 1038-1044, 1993.
16. Skehan, P., Storeng, R., Scudiero, D., Monks, A., James, M., Vistica, D., Warren, Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82: 1107-1112, 1990.
17. Perez, R., Godwin, A. K., Handel, L. M., and Hamilton, T. C. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays in human ovarian carcinoma cell lines. Eur. J. Cancer, 29A: 395-399, 1993.
18. Russell, P. J., Raghavan, D., Philips, J., and Gregory, P. Applications of the xenograft as a model of invasive transitional cell carcinoma of the bladder. Prog. Clin. Biol. Res., 260: 167-181, 1988.
19. Glaves, D., Murray, M. K., and Raghavan, D. Novel bifunctional anthracycline and nitrosourea chemotherapy for human bladder cancer: analysis in a preclinical survival model. Clin. Cancer Res., 2: 1315-1319, 1996.
20. Parsons, J. C., Bellnier, D., Johnson, P., Oseroff, A., Sharma, A., Bernacki, R. J., and Greco, W. R. Computer hardware/software system for recording and analyzing data from photodynamic therapy and chemotherapy rodent tumor growth. Proc. Am. Assoc. Cancer Res. Annu. Meet., 36: 609, 1995.
21. 1-acetyltransferase purified from cultured melanoma cells. Arch. Biochem. Biophys., 284: 238-244, 1991.
22. Kramer, D. L., Mett, H., Regenass, U., Diegelman, P., and Porter, C. W. Stable amplification of the S-adenosylmethionine decarboxylase gene in chinese hamster ovary cells. J. Biol. Chem., 270: 2124-2132, 1995.
23. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 22: 248-254, 1976.